FDA Approves Glaxo Drug to Treat Chronic Leukemia
October 27, 2009
Boston (DbTechNo) - The Food and Drug Administration have given approval to a drug called Arzerra, for the treatment of a type of chronic leukemia.
The approval was fast tracked, meaning that it was given priority review status based on the fact that patients with the type of leukemia the drug is approved for have limited treatment options.
Arzerra is made by GlaxoSmithKline, and is approved to treat a type of leukemia known as chronic lymphocytic leukemia, which is a rare blood and bone marrow cancer.
Despite being approved, GlaxoSmithKline will still need to conduct clinical trials on the drug to further insure it works and is safe.
Breaking News
Sandra Bullock Not Attending London Movie PremierBoston (DbTechNo) - It is being reported that actress Sandra Bullock will not be attending the London premiere of The Blind...
Environmental Protection Agency Reviewing Fle and Tick Product LabellingThe Environmental Protection Agency (EPA) will be taking a closer look at flea and tick products for dogs and cats after...
American Idol Wannabes Take to the StageAmerican Idol featured performances by the top 12 contestants last night, all of whom sang a song from the Rolling Stones. As...
Comments
All comments are moderated.
If your comment is approved, it will be posted within 24 hours